Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nucleus Accumbens | 8 | 2026 | 47 | 2.900 |
Why?
|
| Ethanol | 9 | 2026 | 329 | 2.060 |
Why?
|
| Neurons | 12 | 2025 | 940 | 1.880 |
Why?
|
| Binge Drinking | 3 | 2026 | 38 | 1.590 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 8 | 2014 | 31 | 1.480 |
Why?
|
| Synaptic Transmission | 4 | 2026 | 151 | 1.460 |
Why?
|
| Neural Inhibition | 2 | 2025 | 30 | 1.330 |
Why?
|
| Prefrontal Cortex | 2 | 2026 | 127 | 1.070 |
Why?
|
| Sex Characteristics | 2 | 2026 | 211 | 0.970 |
Why?
|
| GABAergic Neurons | 2 | 2025 | 38 | 0.930 |
Why?
|
| Dopamine | 3 | 2024 | 108 | 0.790 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 2 | 2014 | 4 | 0.730 |
Why?
|
| Action Potentials | 4 | 2017 | 113 | 0.690 |
Why?
|
| Corpus Striatum | 3 | 2023 | 98 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 10 | 2026 | 3468 | 0.550 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 152 | 0.530 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 16 | 0.520 |
Why?
|
| Long-Term Synaptic Depression | 2 | 2014 | 17 | 0.490 |
Why?
|
| Long-Term Potentiation | 2 | 2014 | 42 | 0.480 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2012 | 90 | 0.480 |
Why?
|
| Drug Tolerance | 3 | 2009 | 33 | 0.430 |
Why?
|
| Mice | 14 | 2026 | 11100 | 0.430 |
Why?
|
| Animals | 22 | 2026 | 21310 | 0.410 |
Why?
|
| Nerve Tissue Proteins | 1 | 2014 | 430 | 0.360 |
Why?
|
| Patch-Clamp Techniques | 7 | 2014 | 133 | 0.320 |
Why?
|
| Interpeduncular Nucleus | 2 | 2024 | 21 | 0.320 |
Why?
|
| Locomotion | 2 | 2019 | 114 | 0.310 |
Why?
|
| Interleukin-4 | 1 | 2008 | 147 | 0.270 |
Why?
|
| Potassium Channels, Calcium-Activated | 2 | 2004 | 15 | 0.270 |
Why?
|
| Muscle, Smooth | 1 | 2008 | 135 | 0.260 |
Why?
|
| Feeding Behavior | 1 | 2008 | 263 | 0.250 |
Why?
|
| Mice, Transgenic | 4 | 2025 | 1285 | 0.250 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2026 | 8 | 0.240 |
Why?
|
| Optogenetics | 1 | 2025 | 31 | 0.230 |
Why?
|
| Electrophysiology | 3 | 2014 | 89 | 0.230 |
Why?
|
| Male | 10 | 2026 | 30812 | 0.220 |
Why?
|
| Autistic Disorder | 1 | 2007 | 149 | 0.220 |
Why?
|
| Intellectual Disability | 1 | 2007 | 175 | 0.210 |
Why?
|
| Morphine | 1 | 2004 | 60 | 0.210 |
Why?
|
| Dopamine Agonists | 2 | 2014 | 22 | 0.200 |
Why?
|
| Sex Factors | 1 | 2026 | 989 | 0.190 |
Why?
|
| Age Factors | 2 | 2026 | 1580 | 0.190 |
Why?
|
| Receptors, Glycine | 1 | 2002 | 9 | 0.190 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2023 | 34 | 0.190 |
Why?
|
| Calcium | 4 | 2012 | 583 | 0.180 |
Why?
|
| Phosphorylation | 3 | 2014 | 960 | 0.170 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2008 | 623 | 0.170 |
Why?
|
| Mice, Knockout | 4 | 2009 | 2152 | 0.160 |
Why?
|
| Dopaminergic Neurons | 1 | 2019 | 37 | 0.150 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2188 | 0.140 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 43 | 0.140 |
Why?
|
| Potassium Channel Blockers | 2 | 2017 | 23 | 0.140 |
Why?
|
| Rats | 5 | 2008 | 1996 | 0.140 |
Why?
|
| Cocaine | 1 | 2019 | 101 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2017 | 27 | 0.130 |
Why?
|
| Hippocampus | 2 | 2017 | 274 | 0.130 |
Why?
|
| Membrane Potentials | 3 | 2010 | 138 | 0.130 |
Why?
|
| Luciferases | 1 | 2017 | 105 | 0.130 |
Why?
|
| Ion Channels | 1 | 2017 | 92 | 0.130 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 2 | 2014 | 35 | 0.130 |
Why?
|
| Neural Pathways | 1 | 2017 | 102 | 0.130 |
Why?
|
| HEK293 Cells | 2 | 2019 | 616 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2019 | 425 | 0.120 |
Why?
|
| N-Methylaspartate | 2 | 2007 | 16 | 0.110 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2012 | 46 | 0.110 |
Why?
|
| Synapses | 1 | 2017 | 192 | 0.110 |
Why?
|
| Habenula | 1 | 2015 | 15 | 0.110 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2015 | 38 | 0.110 |
Why?
|
| Ventral Tegmental Area | 1 | 2015 | 38 | 0.110 |
Why?
|
| Spider Venoms | 1 | 2014 | 3 | 0.110 |
Why?
|
| Quinpirole | 1 | 2014 | 5 | 0.110 |
Why?
|
| Benzopyrans | 1 | 2014 | 6 | 0.110 |
Why?
|
| Adamantane | 1 | 2014 | 5 | 0.110 |
Why?
|
| Charybdotoxin | 1 | 2014 | 4 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2014 | 22 | 0.110 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2014 | 24 | 0.110 |
Why?
|
| Tissue Culture Techniques | 1 | 2014 | 33 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2014 | 45 | 0.110 |
Why?
|
| Cell Line | 3 | 2008 | 2036 | 0.110 |
Why?
|
| Potassium | 1 | 2014 | 97 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2014 | 94 | 0.100 |
Why?
|
| Nicotine | 1 | 2015 | 118 | 0.100 |
Why?
|
| RNA Interference | 1 | 2017 | 643 | 0.100 |
Why?
|
| Glycine | 2 | 2004 | 49 | 0.100 |
Why?
|
| RNA, Small Interfering | 2 | 2017 | 980 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2009 | 704 | 0.090 |
Why?
|
| Anxiety | 1 | 2015 | 422 | 0.090 |
Why?
|
| Ion Channel Gating | 2 | 2017 | 44 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2012 | 165 | 0.080 |
Why?
|
| Signal Transduction | 3 | 2017 | 3148 | 0.080 |
Why?
|
| Humans | 10 | 2019 | 64778 | 0.080 |
Why?
|
| Protein Methyltransferases | 1 | 2010 | 13 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 2 | 2007 | 4 | 0.080 |
Why?
|
| Membrane Lipids | 1 | 2009 | 25 | 0.080 |
Why?
|
| Small-Conductance Calcium-Activated Potassium Channels | 1 | 2009 | 1 | 0.080 |
Why?
|
| Affect | 1 | 2010 | 128 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2009 | 83 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 202 | 0.070 |
Why?
|
| Time Factors | 2 | 2014 | 3753 | 0.070 |
Why?
|
| Histamine | 1 | 2008 | 21 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2010 | 236 | 0.070 |
Why?
|
| Alcoholism | 2 | 2009 | 328 | 0.070 |
Why?
|
| Interleukin-13 | 1 | 2008 | 37 | 0.070 |
Why?
|
| Animals, Newborn | 3 | 2017 | 241 | 0.070 |
Why?
|
| Bronchi | 1 | 2008 | 84 | 0.070 |
Why?
|
| RNA Stability | 1 | 2008 | 104 | 0.070 |
Why?
|
| Toxins, Biological | 1 | 2007 | 6 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2008 | 130 | 0.070 |
Why?
|
| RNA Splicing | 1 | 2008 | 165 | 0.060 |
Why?
|
| Translocation, Genetic | 1 | 2007 | 74 | 0.060 |
Why?
|
| Protein Subunits | 2 | 2004 | 169 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 197 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 269 | 0.060 |
Why?
|
| Alcohol Drinking | 1 | 2009 | 322 | 0.060 |
Why?
|
| Cloning, Molecular | 1 | 2007 | 384 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 405 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 543 | 0.060 |
Why?
|
| Models, Molecular | 1 | 2009 | 1157 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 670 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2007 | 439 | 0.050 |
Why?
|
| Female | 2 | 2026 | 33765 | 0.050 |
Why?
|
| Cell Compartmentation | 1 | 2004 | 35 | 0.050 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 38 | 0.050 |
Why?
|
| Electric Conductivity | 1 | 2004 | 52 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 38 | 0.050 |
Why?
|
| Tegmentum Mesencephali | 1 | 2024 | 6 | 0.050 |
Why?
|
| Dendrites | 1 | 2004 | 60 | 0.050 |
Why?
|
| Organ Culture Techniques | 2 | 2019 | 62 | 0.050 |
Why?
|
| Clozapine | 1 | 2003 | 32 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 1633 | 0.050 |
Why?
|
| Peptides | 1 | 2007 | 588 | 0.050 |
Why?
|
| Receptors, Presynaptic | 1 | 2023 | 1 | 0.050 |
Why?
|
| Glycine Agents | 1 | 2002 | 4 | 0.050 |
Why?
|
| Strychnine | 1 | 2002 | 4 | 0.050 |
Why?
|
| GABA Agonists | 1 | 2002 | 4 | 0.050 |
Why?
|
| Picrotoxin | 1 | 2002 | 5 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2002 | 19 | 0.050 |
Why?
|
| Kinetics | 1 | 2004 | 758 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2009 | 749 | 0.050 |
Why?
|
| Oocytes | 1 | 2003 | 201 | 0.040 |
Why?
|
| Zinc | 1 | 2002 | 95 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2003 | 302 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 2277 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2004 | 524 | 0.040 |
Why?
|
| Mutation | 1 | 2007 | 2658 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2004 | 1572 | 0.030 |
Why?
|
| Cadmium Chloride | 1 | 2017 | 2 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2017 | 3 | 0.030 |
Why?
|
| Tetraethylammonium | 1 | 2017 | 9 | 0.030 |
Why?
|
| Tetrodotoxin | 1 | 2017 | 11 | 0.030 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 12 | 0.030 |
Why?
|
| Synaptic Potentials | 1 | 2017 | 6 | 0.030 |
Why?
|
| Camptothecin | 1 | 2017 | 29 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2017 | 364 | 0.030 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 27 | 0.030 |
Why?
|
| Nerve Net | 1 | 2015 | 102 | 0.030 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 125 | 0.030 |
Why?
|
| Adaptation, Ocular | 1 | 2010 | 1 | 0.020 |
Why?
|
| Immobility Response, Tonic | 1 | 2010 | 2 | 0.020 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2010 | 6 | 0.020 |
Why?
|
| Electroshock | 1 | 2010 | 6 | 0.020 |
Why?
|
| Sweetening Agents | 1 | 2010 | 20 | 0.020 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2010 | 37 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 2010 | 27 | 0.020 |
Why?
|
| Sucrose | 1 | 2010 | 29 | 0.020 |
Why?
|
| Exploratory Behavior | 1 | 2010 | 36 | 0.020 |
Why?
|
| Maze Learning | 1 | 2010 | 51 | 0.020 |
Why?
|
| Food Preferences | 1 | 2010 | 52 | 0.020 |
Why?
|
| Fear | 1 | 2010 | 70 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 146 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 374 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 700 | 0.020 |
Why?
|
| Motor Activity | 1 | 2010 | 347 | 0.020 |
Why?
|
| COS Cells | 1 | 2007 | 180 | 0.020 |
Why?
|
| Cerebellum | 1 | 2007 | 94 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 131 | 0.020 |
Why?
|
| Chromatin | 1 | 2010 | 640 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2004 | 143 | 0.010 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2004 | 87 | 0.010 |
Why?
|
| Depression, Chemical | 1 | 2003 | 11 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 71 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 493 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 897 | 0.010 |
Why?
|